Close Menu

SAIC-Frederick

The company will develop the cancer-targeted antibodies for SAIC-Frederick under an NCI proteomics initiative.

The new building will house a wide range of advanced research and development technologies — from biopharmaceutical development and manufacturing to genomics and nanotechnology — that ATPI partners can access by collaborating with NCI.

According to the solicitation, caBIG is seeking a contractor who can "maintain and enhance all components of caB2B in terms of functionality and usability along with maintainability, security, and performance through focused refactoring."

The NCI contractor will use Roche's sequence capture technology and FLX sequencer on cancer genomics tests.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.